뒤로
WuXi Biologics (Cayman) Inc.(2269.HK) 가격
2269.HK 주가 차트
WUXI BIO (2269.HK)
WuXi Biologics (Cayman) Inc.
HK$38.4
3.78%
$1.39
장 종료: Jan 21, 16:00:00 HKT
최신 수익 결과: Q4 '21
보고됨: 2022-03-22
역사적 수익
분기별
연간
EPS
수익
Earnings FAQ
2269.HK의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
WuXi Biologics (Cayman) Inc. 2269.HK의 지난 분기 매출 실적은 어땠나요?
WuXi Biologics (Cayman) Inc.의 매출 추정치는 얼마인가요?
WuXi Biologics (Cayman) Inc.의 수익 품질 점수는 얼마인가요?
WuXi Biologics (Cayman) Inc.는 언제 수익을 보고하나요?
WuXi Biologics (Cayman) Inc.의 예상 수익은 얼마인가요?
WuXi Biologics (Cayman) Inc.은 수익 기대치를 충족했나요?
주요 통계
이전 종가
$37.1
시가
$37
일일 범위
$36.84 - $38.46
52주 범위
$16.2 - $42.6
거래량
29.4M
평균 거래량
33.9M
EPS(TTM)
1.09
배당수익률
--
시가총액
$158.5B
WUXI BIO란 무엇인가요?
Wuxi Biologics (Cayman), Inc. is an investment holding company, which provides end-to-end solutions and services for biologics discovery, development, and manufacturing services and manufacturing of biologics products. The company is headquartered in Wuxi, Jiangsu and currently employs 12,552 full-time employees. The company went IPO on 2017-06-13. The firm mainly operates its business through two segments. The Biologics segment mainly engages in the provision of biologics discovery, development and manufacturing. The WuXi XDC (XDC) segment mainly engages in the provision of contract research, development and manufacturing organization (CRDMO) services for antibody-drug conjugate (ADCs) and various bioconjugates. The firm mainly conducts its business in the domestic and overseas markets.